Bayer

LISTEN: Glyphosate, Bayer, and the courts

TNL Editor in Chief Carey Gillam joins the radio show KZFR radio’s Ecotopia show to discuss the current legal landscape around Bayer and glyphosate.

Bayer’s proposed Roundup settlement violates Constitution, new legal filing claims

Bayer’s proposed $7.25 billion class action settlement is a “sweetheart deal” that violates the US Constitution by running “roughshod over basic due process rights, according to a court filing Thursday that seeks to undo the nationwide program.

With a rich payout to lawyers but little for plaintiffs, Bayer’s Roundup settlement faces critics, doubts

A class action settlement proposed in the nationwide Roundup litigation would award $675 million to lawyers who negotiated the settlement, while plaintiffs suffering from cancer would receive, on average, $10,000 to $165,000 each, according to a new court filing in the case.

US judge calls proposed Bayer Roundup settlement a “filthy” deal

In a tense hearing on Thursday, a federal judge who has been overseeing thousands of cases in nationwide Roundup litigation expressed scathing criticism of a proposed class action settlement that Roundup maker Bayer is pushing forward in a Missouri court.

No safe bets – Supreme Court glyphosate case seen too close to call

Monday’s Supreme Court hearing over a federal law governing pesticide regulations left observers largely unsure how the court will rule in the case involving the former Monsanto company and the herbicide glyphosate, with many seeing the ultimate decision as too close to call.

WATCH: Relive a historic day at the Supreme Court

Advocates, politicians, and concerned citizens gathered at the US Supreme Court this Monday as the justices heard arguments in a landmark pesticide case with major implications for corporate liability and consumer safety.

Supreme Court justices weigh Monsanto bid to block warning lawsuits

Members of the US Supreme Court peppered lawyers for the former Monsanto Co. with a barrage of questions over pesticide regulation on Monday, wrestling over whether federal law preempts state actions that permit consumers to sue companies for failing to warn of product risks such as cancer.